...
首页> 外文期刊>Diabetes, obesity & metabolism >A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea.
【24h】

A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea.

机译:沙格列汀作为补充疗法治疗2型糖尿病患者的疗效和安全性的随机对照试验,并且对二甲双胍和磺脲类药物的血糖控制不充分。

获取原文
获取原文并翻译 | 示例
           

摘要

Addition of saxagliptin 5?mg/day in patients inadequately controlled on metformin and sulphonylurea effectively improved glycaemic control and was well tolerated.
机译:对二甲双胍和磺脲类药物控制不力的患者,每天补充沙格列汀5?mg可以有效改善血糖控制,并且耐受性良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号